UBS Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,378
Closed -$125K 8018
2020
Q3
$125K Sell
2,378
-1,837
-44% -$96.6K ﹤0.01% 4236
2020
Q2
$140K Sell
4,215
-29,809
-88% -$990K ﹤0.01% 4251
2020
Q1
$925K Sell
34,024
-36,615
-52% -$995K ﹤0.01% 2724
2019
Q4
$1.39M Sell
70,639
-46,775
-40% -$923K ﹤0.01% 3066
2019
Q3
$1.52M Buy
117,414
+112,223
+2,162% +$1.45M ﹤0.01% 2855
2019
Q2
$65K Buy
5,191
+2,824
+119% +$35.4K ﹤0.01% 4847
2019
Q1
$34K Sell
2,367
-72,015
-97% -$1.03M ﹤0.01% 5033
2018
Q4
$821K Buy
74,382
+70,882
+2,025% +$782K ﹤0.01% 3143
2018
Q3
$92K Buy
3,500
+3,055
+687% +$80.3K ﹤0.01% 4793
2018
Q2
$9K Sell
445
-89,756
-100% -$1.82M ﹤0.01% 6296
2018
Q1
$1.64M Buy
90,201
+87,997
+3,993% +$1.6M ﹤0.01% 2684
2017
Q4
$31K Sell
2,204
-2,591
-54% -$36.4K ﹤0.01% 5256
2017
Q3
$89K Buy
4,795
+1,536
+47% +$28.5K ﹤0.01% 4512
2017
Q2
$55K Buy
3,259
+1,096
+51% +$18.5K ﹤0.01% 4674
2017
Q1
$29K Sell
2,163
-34,729
-94% -$466K ﹤0.01% 4986
2016
Q4
$555K Buy
36,892
+26,669
+261% +$401K ﹤0.01% 3235
2016
Q3
$120K Sell
10,223
-2,870
-22% -$33.7K ﹤0.01% 4060
2016
Q2
$142K Sell
13,093
-1,658
-11% -$18K ﹤0.01% 3977
2016
Q1
$136K Sell
14,751
-71,471
-83% -$659K ﹤0.01% 4035
2015
Q4
$1.28M Buy
86,222
+69,794
+425% +$1.04M ﹤0.01% 2520
2015
Q3
$270K Sell
16,428
-30,579
-65% -$503K ﹤0.01% 3513
2015
Q2
$1.07M Buy
47,007
+24,015
+104% +$548K ﹤0.01% 2751
2015
Q1
$350K Sell
22,992
-106,987
-82% -$1.63M ﹤0.01% 3433
2014
Q4
$1.57M Buy
+129,979
New +$1.57M ﹤0.01% 2416